Get Your Personalized Supplement StackSupplement Stack Quiz

Copper Peptide GHK

Also known as: GHK, Copper peptide GHK, GHK-Cu, Glycyl-L-histidyl-L-lysine

Overview

Glycyl-L-histidyl-L-lysine (GHK) is an endogenous tripeptide naturally found in human plasma and tissues. It is particularly known for its high affinity for copper ions, forming the GHK-Cu complex, which is the biologically active form. GHK-Cu is extensively researched for its multifaceted roles in tissue repair, anti-inflammatory and antioxidant activities, and significant gene regulation. It plays a crucial role in skin remodeling, accelerating wound healing, and exhibiting neuroprotective effects. While research on GHK-Cu is moderately advanced with a growing body of in vitro, animal, and some human data, large-scale clinical trials are still limited. The current evidence primarily stems from preclinical studies and pilot clinical trials, with fewer large randomized controlled trials or meta-analyses available. Its natural occurrence and broad biological activities make it a promising compound in regenerative medicine and anti-aging applications.

Benefits

GHK-Cu offers several evidence-based benefits, primarily in tissue repair, neuroprotection, and anti-inflammatory/antioxidant effects. It significantly promotes collagen synthesis, glycosaminoglycan production, and angiogenesis, which are crucial for wound healing and skin regeneration. This makes it highly beneficial for dermatological applications and recovery from injuries. In neuroprotection, GHK-Cu exhibits potent antioxidant and anti-inflammatory properties, safeguarding against copper- and zinc-induced protein aggregation and cell death, which are relevant in neurodegenerative conditions. A pilot clinical study involving 16 IBD patients showed that rectal GHK-Cu treatment reduced disease severity by approximately 60% after 12 weeks, indicating its potential in inflammatory bowel diseases. Furthermore, GHK-Cu modulates gene expression, suppressing genes associated with metastatic cancer and upregulating those involved in tissue maintenance and repair, suggesting potential anti-cancer properties. While most data are preclinical or from small-scale studies, the consistent positive findings across various models highlight its therapeutic potential. Benefits in skin and wound healing are typically observed within weeks, while systemic effects like neuroprotection and gene regulation may require sustained exposure.

How it works

GHK-Cu exerts its effects primarily by binding copper ions with high affinity, forming the GHK-Cu complex. This complex enhances copper bioavailability and modulates copper redox activity, which is crucial for various enzymatic processes. It effectively reduces copper- and zinc-induced oxidative stress and protein aggregation, thereby protecting cells from metal-induced toxicity. A key mechanism involves its broad modulation of gene expression, influencing genes related to inflammation, tissue remodeling, neuroprotection, and even cancer pathways. GHK-Cu also enhances the activity of antioxidant defense enzymes and promotes the synthesis of extracellular matrix components, vital for tissue integrity and repair. It is believed to act as an epigenetic modifier, influencing gene transcription. While its absorption and systemic bioavailability in humans are not fully characterized, topical and localized administrations have demonstrated significant biological activity.

Side effects

GHK-Cu is generally considered safe and non-toxic at physiological and therapeutic concentrations, based on current research. No significant adverse effects have been reported in animal models or small human studies conducted to date. The literature does not document any known serious drug interactions or contraindications associated with GHK-Cu. However, it is important to note that the safety profile in specific populations, such as pregnant or pediatric individuals, or those with severe underlying medical conditions, has not been well studied. As with any supplement, individual sensitivities can vary, but the overall safety profile appears favorable given its endogenous nature and lack of reported toxicity in available research.

Dosage

There is currently no established standardized dosing for GHK-Cu due to the limited number of large-scale clinical trials. In a pilot clinical study for Inflammatory Bowel Disease (IBD), rectal administration of GHK-Cu was used over 12 weeks, showing positive effects. For topical skin applications, concentrations typically vary widely but are generally in the low micromolar range. The optimal dosing and protocols for systemic administration of GHK-Cu remain to be fully defined through further research. As an endogenous peptide, its physiological concentrations are low, and therapeutic concentrations are still being explored. There are no established upper limits or safety thresholds for GHK-Cu, but current research suggests a favorable safety profile at studied concentrations.

FAQs

Is GHK-Cu safe?

Yes, current evidence from preclinical and small human studies suggests GHK-Cu is generally safe and non-toxic at physiological and therapeutic concentrations, with no significant adverse effects reported.

How quickly does GHK-Cu work?

Effects on skin and wound healing may be observed within weeks. Systemic effects, such as neuroprotection and gene regulation, likely require longer, sustained exposure to manifest.

Is GHK-Cu effective orally?

Data on oral bioavailability of GHK-Cu are limited. Most studies demonstrating efficacy have utilized topical or localized delivery methods, such as skin creams or rectal administration.

Can GHK-Cu treat neurodegenerative diseases?

Preclinical evidence for GHK-Cu's neuroprotective properties is promising, showing protection against metal-induced toxicity. However, robust clinical data in humans for treating neurodegenerative diseases are currently lacking.

Research Sources

https://academic.oup.com/metallomics/article/16/5/mfae019/7643839 – This in vitro study demonstrated that GHK effectively prevents copper- and zinc-induced protein aggregation and cell death in various cell models. It also showed that GHK reduces copper redox activity, highlighting its role in mitigating metal-induced oxidative stress and toxicity at a cellular level.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1551843/full – This research combined animal models and a pilot clinical study. It found that GHK-Cu alleviated colitis symptoms in mice and, in a small pilot group of 16 IBD patients, led to a significant 60% reduction in disease severity after 12 weeks of rectal administration, suggesting its potential in inflammatory bowel diseases.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3359723/ – This review and gene expression study synthesized existing research, concluding that GHK-Cu exhibits neuroprotective, antioxidant, and anti-inflammatory properties. It also highlighted GHK-Cu's ability to broadly regulate gene expression, influencing pathways related to tissue repair and protection, though primarily based on preclinical data.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/ – This review article summarized the evidence for GHK-Cu's role in promoting wound healing, tissue remodeling, and angiogenesis. It detailed how GHK-Cu modulates copper metabolism to support these regenerative processes, emphasizing its importance in dermatological and wound care applications.
https://neoplasiaresearch.com/index.php/jao/article/view/217 – This gene expression analysis, conducted on cell lines, revealed that GHK modulates genes involved in cancer suppression and tissue remodeling. The findings suggest a potential role for GHK in influencing cellular pathways relevant to cancer, though this was an in vitro study and requires further clinical investigation.